Literature DB >> 16125109

Signal-transduction networks and the regulation of muscle protein degradation.

Nathaniel J Szewczyk1, Lewis A Jacobson.   

Abstract

Protein degradation in muscle functions in maintaining normal physiological homeostasis and adapting to new homeostatic states, and is required for muscle wasting or atrophy in various pathological states. The interplay between protein synthesis and degradation to maintain homeostasis is complex and responds to a variety of autocrine and intercellular signals from neuronal inputs, hormones, cytokines, growth factors and other regulatory molecules. The intracellular events that connect extracellular signals to the molecular control of protein degradation are incompletely understood, but likely involve interacting signal-transduction networks rather than isolated pathways. We review some examples of signal-transduction systems that regulate protein degradation, including effectors of proteolysis inducing factor (PIF), insulin and insulin-like growth factor (IGF) and their receptors, and fibroblast growth factor (FGF) and its receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125109     DOI: 10.1016/j.biocel.2005.02.020

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  9 in total

1.  Opposed growth factor signals control protein degradation in muscles of Caenorhabditis elegans.

Authors:  Nathaniel J Szewczyk; Brant K Peterson; Sami J Barmada; Leah P Parkinson; Lewis A Jacobson
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

Review 2.  Exercise and the control of muscle mass in human.

Authors:  Marc Francaux; Louise Deldicque
Journal:  Pflugers Arch       Date:  2018-10-11       Impact factor: 3.657

3.  Prenatal exposure to phthalate and decreased body mass index of children: a systematic review and meta-analysis.

Authors:  Dong-Wook Lee; Hyun-Mook Lim; Joong-Yub Lee; Kyung-Bok Min; Choong-Ho Shin; Young-Ah Lee; Yun-Chul Hong
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

Review 4.  Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.

Authors:  Norman Mangner; Yae Matsuo; Gerhard Schuler; Volker Adams
Journal:  Endocrine       Date:  2012-08-19       Impact factor: 3.633

5.  Induction of muscle weakness by local inflammation: an experimental animal model.

Authors:  S Bicer; P J Reiser; S Ching; N Quan
Journal:  Inflamm Res       Date:  2009-04       Impact factor: 4.575

6.  Identification and functional clustering of genes regulating muscle protein degradation from amongst the known C. elegans muscle mutants.

Authors:  Freya Shephard; Ademola A Adenle; Lewis A Jacobson; Nathaniel J Szewczyk
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

Review 7.  Integrated control of protein degradation in C. elegans muscle.

Authors:  Susann Lehmann; Freya Shephard; Lewis A Jacobson; Nathaniel J Szewczyk
Journal:  Worm       Date:  2012-07-01

Review 8.  Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.

Authors:  David Nury; Christine Doucet; Olivier Coux
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

9.  FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension.

Authors:  John Eash; Aaron Olsen; Gert Breur; Dave Gerrard; Kevin Hannon
Journal:  BMC Musculoskelet Disord       Date:  2007-04-10       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.